Summary: Virax Biolabs Group Limited has secured a distribution agreement to commercialize RT-PCR Mpox virus detection kits across 13 European countries and Gulf Cooperation Council (GCC) nations.

Takeaways:

  1. Wide Distribution Reach: The agreement enables Virax Biolabs to distribute Mpox virus detection kits in key European markets and GCC countries, expanding access to critical diagnostic tools.
  2. High-Performance Kits: The RT-PCR kits are CE-marked and MHRA-authorized, delivering results with 96.7% sensitivity and 93.72% specificity in under 70 minutes, ensuring reliable and timely diagnostics.
  3. Commitment to Public Health: Virax Biolabs emphasizes its dedication to equipping healthcare professionals with essential tools to diagnose and mitigate the spread of Mpox virus, particularly in at-risk communities across major regions.

Virax Biolabs Group Limited has entered into a distribution agreement with a supplier of (RT) PCR Mpox virus detection kits to commercialize them in 13 European countries as well as members of the Gulf Cooperation Council (“GCC”) including Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates.

Mpox Virus Detection Kits

The RT-PCR Mpox virus detection kits are CE-marked for sale in Europe and also authorized by the Medicines and Healthcare products Regulatory Agency (MHRA), the product regulatory agency for the United Kingdom. These tests perform with a sensitivity of 96.7% and specificity of 93.72%, with the ability to deliver results in under 70 minutes.

“Mpox virus poses a serious threat, and we continue to be committed to equipping healthcare professionals with the necessary tools to diagnose and mitigate its spread,” says James Foster, CEO of Virax Biolabs. “Our partnership with our suppliers, a leader in sales of diagnostic reagents and equipment related to infectious pathogens, underscores our commitment and enables us to reach at-risk communities across major geographies.”

Under the terms of the agreement, Virax is authorized to import, sell and distribute Virax-branded Mpox virus Nucleic Acid Detection Kits in European countries including the United Kingdom, France, Portugal, The Netherlands, Belgium, Sweden, Finland, Denmark, Norway, Germany, Spain, Switzerland, Austria, as well as the GCC set of nations.Potential interested parties in the company’s Early Release Partnership Program (“ERPP”) for the Mpox RT-PCR Detection kits can contact Virax Biolabs representatives.